Abstract
Purpose
The aim was to analyze the findings from the 2019 Global Burden of Disease (GBD-2019) study on type-2 diabetes in Mexico’s adolescents and young adults, at a national and subnational scale from 1990 to 2019, and to assess its association with the socio-demographic, and the healthcare access and quality indices.
Methods
Following the GBD-2019 study, young-onset type 2 diabetes mortality, premature mortality, years lived with disability and disability-adjusted life-years (DALYs) are reported.
Results
A significant increase in the overall number of deaths attributed to young-onset T2D was found. There was a non-significant decrease in mortality rates for both sexes across most age groups. DALYs in men were greater than that in women, with almost half attributed to premature death in males, while disability accounted for two thirds of DALYs in females. The DALY rate increased significantly in most states. Premature mortality decreased, while disability increased across all age-groups, and in all states for both sexes.
Conclusion
The surge in disability corresponded to the upsurge in obesity and overweight rates in Mexico among the younger population. This happened despite improvements in socio-economic status and healthcare access in Mexico which underscores the need for diabetes education in the public health sector.
Similar content being viewed by others
Data availability
All data is publicly available at https://vizhub.healthdata.org/gbd-results/.
References
Federation ID. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
Funakoshi M, Azami Y, Matsumoto H, Ikota A, Ito K, Okimoto H, et al. Socioeconomic status and type 2 diabetes complications among young adult patients in Japan. PLoS ONE. 2017;12: e0176087.
GBD-2019 GBoDS. Global burden of Disease Study 2019 (GBD 2019) results. Seattle: Institute for Health Metrics and Evaluation (IHME); 2020.
Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, De la Cruz-Góngora V, Rivera-Dommarco J, et al. Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020. Salud Publica Mexico. 2021;63:725–33.
Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE. Young-onset type 2 diabetes mellitus — implications for morbidity and mortality. Nat Rev Endocrinol. 2020;16:321–31.
Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5:234–44.
Adam F, Diatri M, Adam J, Seweng A, Tai E. Prevalence of metabolic syndrome in young adults. Int J Sci Res (Raipur). 2015;4:1320–3.
Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6:69–80.
Seiglie JA, Marcus M-E, Ebert C, Prodromidis N, Geldsetzer P, Theilmann M, et al. Diabetes prevalence and its relationship with Education, Wealth, and BMI in 29 low- and Middle-Income Countries. Diabetes Care. 2020;43:767–75.
Cousin E, Duncan BB, Stein C, Ong KL, Vos T, Abbafati C, et al. Diabetes mortality and trends before 25 years of age: an analysis of the global burden of disease study 2019. Lancet Diabetes Endocrinol. 2022;10:177–92.
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. The Lancet. 2020;396:1204–22.
Murray CJ, Lopez AD. Measuring global health: motivation and evolution of the global burden of disease study. The Lancet. 2017;390:1460–4.
Wang H, Abbas KM, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019. The Lancet. 2020;396:1160–203.
Hijar M, Perez-Nunez R, Hidalgo-Solorzano E, Hernandez Prado B, Valdez-Santiago R, Hamilton EB, et al. Unintentional injuries in Mexico, 1990–2017: findings from the global burden of Disease Study 2017. Inj Prev. 2020;26(Suppl 2):i154–i161.
Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. The Lancet. 2018;392:1859–922.
Gillis D, Edwards BPM. The utility of joinpoint regression for estimating population parameters given changes in population structure. Heliyon. 2019;5: e02515.
Institute NC. Joinpoint Trend Analysis Software. United States: National Cancer Institute; 2022.
GBD-2019 GBoDS. The GBD 2019 Socio-Demographic Index. Seattle: Institute for Health Metrics and Evaluation (IHME); 2020.
Haakenstad A, Yearwood JA, Fullman N, Bintz C, Bienhoff K, Weaver MR, et al. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the global burden of Disease Study 2019. Lancet Glob Health. 2022;10:e1715–43.
CONAPO NPC. The 2015 state and municipality marginality-index. Mexico City: National Population Council; 2020.
Collaboration NRF. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet. 2016;387:1513–30.
Florêncio RB, de Araújo Fonseca LG, da Silva VFD, Lima ÍNDF, Gualdi LP. Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: a longitudinal study. BMC Public Health. 2021;21:403.
Gutiérrez-León E, Escamilla-Santiago RA, Martínez-Amezcua P, Bilal U, Lazo M, Ogaz-González R, et al. Trends and effect of marginalization on diabetes mellitus-related mortality in Mexico from 1990 to 2019. Sci Rep. 2022;12:9190.
Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, et al. ISPAD clinical practice consensus guidelines 2018: type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19:28–46.
Candler TP, Mahmoud O, Lynn RM, Majbar AA, Barrett TG, Shield JPH. Continuing rise of type 2 diabetes incidence in children and young people in the UK. Diabet Med. 2018;35:737–44.
Suglia SF, Demmer RT, Wahi R, Keyes KM, Koenen KC. Depressive symptoms during adolescence and young adulthood and the development of type 2 diabetes Mellitus. Am J Epidemiol. 2016;183:269–76.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021;64:275–87.
Arredondo A, Orozco E, Duarte MB, Cuadra M, Recaman AL, Azar A. Trends and challenges in diabetes for middle-income countries: evidence from Mexico. Glob Public Health. 2019;14:227–40.
Breton M-C, Guénette L, Amiche MA, Kayibanda J-F, Grégoire J-P, Moisan J. Burden of diabetes on the ability to work: a systematic review. Diabetes Care. 2013;36:740–9.
Beltran-Sanchez H, Crimmins EM. Biological risk in the mexican population at the turn of the 21st century. J Cross Cult Gerontol. 2013;28:299–316.
Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2016;388:2386–402.
Bello-Chavolla OY, Antonio-Villa NE, Fermín-Martínez CA, Fernández-Chirino L, Vargas-Vázquez A, Ramírez-García D, et al. Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017–2019 and 2020. Diabetes Care. 2022;45:2957–66.
Bello-Chavolla OY, Rojas-Martinez R, Aguilar-Salinas CA, Hernández-Avila M. Epidemiology of diabetes mellitus in Mexico. Nutr Rev. 2017;75:4–12.
Bilsen J. Suicide and youth: risk factors. Front Psychiatry. 2018;9:540.
Collaborators TGO. Health Effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
Hashimoto Y, Hamaguchi M, Tanaka M, Obora A, Kojima T, Fukui M. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Res Clin Pract. 2018;12:4–15.
Alegre-Díaz J, Herrington W, López-Cervantes M, Gnatiuc L, Ramirez R, Hill M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961–71.
Whittemore R, Vilar-Compte M, De La Cerda S, Marron D, Conover R, Delvy R, et al. Challenges to diabetes self-management for adults with type 2 diabetes in low-resource settings in Mexico City: a qualitative descriptive study. Int J Equity Health. 2019;18:133.
Soto-Estrada G, Moreno Altamirano L, García-García JJ, Ochoa Moreno I, Silberman M. Trends in frequency of type 2 diabetes in Mexico and its relationship to dietary patterns and contextual factors. Gac Sanit. 2018;32:283–90.
Dávila-Cervantes CA, Agudelo-Botero M. Sex disparities in the epidemic of type 2 diabetes in Mexico: national and state level results based on the Global Burden of Disease Study, 1990–2017. Diabetes, Metabolic Syndrome and Obesity. 2019;12:1023–33.
Al-Saeed AH, Constantino MI, Molyneaux L, D’Souza M, Limacher-Gisler F, Luo C, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of Youth-Onset type 2 diabetes. Diabetes Care. 2016;39:823–9.
Astudillo O. Country in Focus: Mexico’s growing obesity problem. Lancet Diabetes Endocrinol. 2014;2:15–6.
Weller SC, Baer RD, de Alba Garcia JG, Rocha ALS. Are differences between patient and provider explanatory models of diabetes associated with patient self-management and glycemic control? J Health Care Poor Underserved. 2013;24:1498–510.
Malhão TA, Brito AdS, Pinheiro RS, Cabral CdS, Camargo TMCRd, Coeli CM. Sex differences in diabetes Mellitus Mortality Trends in Brazil, 1980–2012. PLoS ONE. 2016;11:e0155996.
Rhodes ET, Prosser LA, Hoerger TJ, Lieu T, Ludwig DS, Laffel LM. Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus. Diabet Med. 2012;29:453–63.
Browne JL, Nefs G, Pouwer F, Speight J. Depression, anxiety and self-care behaviours of young adults with type 2 diabetes: results from the International Diabetes Management and Impact for Long-term empowerment and success (MILES) Study. Diabet Med. 2015;32:133–40.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has no competing interests to declare that are relevant to the content of this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dávila-Cervantes, C.A. The burden of type 2 diabetes in adolescents and young adults in Mexico: analysis from the Global Burden of Disease Study, 1990 to 2019. J Diabetes Metab Disord 22, 1673–1684 (2023). https://doi.org/10.1007/s40200-023-01299-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-023-01299-x